Grants and Contributions:
Title:
COVID-19 High-capacity and Rapid Serological Testing
Agreement Number:
951901
Agreement Value:
$450,000.00
Agreement Date:
Jun 1, 2020 - Feb 28, 2021
Description:
To quantify the strength and nature of the immune response to COVID-19 infection after recovery, the proposed serological tests will measure SARS-CoV-2-reactive IgG and IgM antibodies by rapidly adapting a next-generation immunoassay. By the end of the proposed project, all clinical validation tests required by Health Canada for expedited approval will be complete.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Mississauga, Ontario, CA L5L 4L4
Reference Number:
172-2020-2021-Q1-951901
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
738751494
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The end date of this agreements has been modified by 90 days.
Amendment Date
Dec 11, 2020
Recipient's Legal Name:
Vital Biosciences Inc
Federal Riding Name:
Mississauga--Erin Mills
Federal Riding Number:
35060
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: